IP Library Granted Patent US 9,304,084
Granted Patent B2
US 9,304,084 · App. 14/608,350 · Granted Apr 5, 2016

Spatial positioning of spectrally labeled beads

Inventors: Stephen Empedocles (Mountain View, CA); Andrew Watson (Lexington, MA); Jian Jin (Berkeley, CA)
Assignee: Life Technologies Corporation
G01N21/6428B01L3/5025B01L3/5085B01L3/502761G01N21/25G01N21/253G01N21/272G01N21/274G01N21/278G01N21/6452G01N21/6486G01N21/6489G01N33/54373B01J2219/005B01J2219/00317B01J2219/00432B01J2219/00574B01J2219/00576B01J2219/00578B01J2219/00585B01J2219/00596B01J2219/00648B01J2219/00657B01J2219/00659B01J2219/00677B01J2219/00707B01J2219/00722B01J2219/00743B01L3/502715B01L3/545B01L2200/0668B01L2300/021B01L2300/0819B01L2300/0829B01L2400/0454B01L2400/0457B82Y30/00C40B40/06C40B60/14G01N21/6456G01N2015/0092G01N2015/1472G01N2015/1497G01N2021/6441G01N2021/6482G01N2035/00158G01N2035/00742G01N2035/00752G01N2201/04G01N2201/06113
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,304,084
App. No.
14/608,350
Granted
Apr 5, 2016
Kind
B2
Abstract

Devices, systems, kits, and methods for detecting and/or identifying a plurality of spectrally labeled bodies well-suited for performing multiplexed assays. By spectrally labeling the beads with materials which generate identifiable spectra, a plurality of beads may be identified within the fluid. Reading of the beads is facilitated by restraining the beads in arrays, and/or using a focused laser.

Claims (25)

1. A multiplex assay, comprising:

an assay substrate; and

a plurality of spectrally labeled bodies affixed to the assay substrate in a spatially resolved configuration, wherein each of the spectrally labeled bodies includes a plurality of different markers used to encode discrete and different emission spectra, wherein each emission spectrum has a plurality of signals at differing wavelengths.

2. The multiplex assay of claim 1 wherein the spectrum identifies each of the spectrally labeled bodies.

3. The multiplex assay of claim 1 wherein the markers are fluorescent labels.

4. The multiplex assay of claim 1 wherein the markers are nanocrystals.

5. The multiplex assay of claim 1 wherein the spectrally labeled bodies are affixed via an affinity binding complex.

6. The multiplex assay of claim 5 wherein the spectrally labeled bodies are affixed via a binding pair.

7. The multiplex assay of claim 6 wherein the binding pair includes a biotinylated structure.

8. A multiplex assay apparatus, comprising:

a sample container holding a sample fluid containing a plurality of spectrally labeled bodies; and

a fluidics assembly configured to wash away spectrally labeled bodies not bound to an identifiable substance, transfer the bound spectrally labeled bodies to a reading container and affix the bound spectrally labeled bodies to the reading container in a spatially resolved configuration, wherein each of the bound spectrally labeled bodies includes a plurality of different markers used to encode discrete and different emission spectra, wherein each emission spectrum has a plurality of signals at differing wavelengths.

9. The multiplex assay apparatus of claim 8 wherein the affixation is via affinity binding.

10. The multiplex assay apparatus of claim 8 wherein the identifiable substance is a biological material.

11. A method for making a multiplex assay, comprising:

affixing a plurality of spectrally labeled bodies to an assay substrate in a spatially resolved configuration, wherein each of the spectrally labeled bodies include a plurality of different markers used to encode discrete and different emission spectra, wherein each emission spectrum has a plurality of signals at differing wavelengths.

12. The method for making the multiplex assay of claim 11 further comprising the step of binding the spectrally labeled bodies to an identifiable substance.

13. The method for making the multiplex assay of claim 12 further comprising the step of transferring the bound spectrally labeled bodies to the assay substrate.

14. The method for making the multiplex assay of claim 13 further comprising the step of washing away spectrally labeled bodies not bound to the identifiable substance.

15. The method for making the multiplex assay of claim 12 wherein the identifiable substance is a biological material.

16. The method for making the multiplex assay of claim 11 wherein the markers are fluorescent labels.

17. The method for making the multiplex assay of claim 11 wherein the affixing step occurs via an affinity binding complex.

18. The method for making the multiplex assay of claim 11 wherein the affixing step occurs via an affinity binding pair.

19. The method for making the multiplex assay of claim 18 wherein the affinity binding pair includes a biotinylated structure.

20. The method for making the multiplex assay of claim 11 wherein the spectrum identifies each of the spectrally labeled bodies.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2016
From: QUANTUM DOT CORPORATION
To: INVITROGEN CORPORATION
Reel/Frame 037797/0832 →
MERGER Recorded Feb 23, 2016
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 037797/0899 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2016
From: EMPEDOCLES, STEPHEN A; WATSON, ANDREW R; JIN, JIAN
To: QUANTUM DOT CORP
Reel/Frame 037740/0946 →
Continuity (6)
Continuation 13777032 · Feb 26, 2013
Continuation 12620475 · Nov 17, 2009
Continuation 11425851 · Jun 22, 2006
Continuation 09827256 · Apr 5, 2001
Provisional Application 60195520 · Apr 6, 2000
Related Publication 20150168393A1 · Jun 18, 2015